Press Release
<< Back
Verastem to Present at Upcoming Conferences
-
16th Annual BIO CEO & Investor Conference on
Tuesday, February 11, 2014 at3:00 p.m. ET at the Waldorf Astoria inNew York City , NY -
Leerink Swann Global Healthcare Conference onWednesday, February 12, 2014 at1:25 p.m. ET at the Waldorf Astoria inNew York City , NY -
21st
International Molecular Medicine Tri-Conference onThursday, February 13 throughFriday, February 14, 2014 at theWestin St. Francis inSan Francisco, CA
Symposium: Targeting Cancer Stem Cells: New Opportunities for
Oncology Therapeutics – Day 1
Presentation: Chair of
session - Preclinical Advances Targeting Cancer Stem Cells
Date
and Time:
Symposium: Targeting Cancer Stem Cells: New Opportunities for
Oncology Therapeutics – Day 2
Presentation: Strategies to
Develop Agents that Preferentially Target Cancer Stem Cells: Clinical
Candidates Targeting FAK and PI3K/mTOR
Date and Time:
Webcasts of the BIO CEO and Leerink Swann presentations can be accessed
by visiting the investors section of the Company’s website at www.verastem.com.
Replays of each of the webcasts will be archived on the
About
Forward-looking statements:
Any statements in this press release about future expectations, plans and prospects for the Company constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements. The Company anticipates that subsequent events and developments will cause the Company’s views to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so.
Source:
Verastem, Inc.
Brian Sullivan, 617-252-9314
bsullivan@verastem.com